Advisory Committee

Mary is the Oral Oncolytic Nurse Navigator for the Norton Cancer Institute in Louisville, Kentucky. She serves on the Executive Council for the National Community Oncology Dispensing Association and is past President of the Greater Louisville Oncology Nursing Society. She has authored chapters for Oncology Nursing Society’s Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (2018 edition), including the chapter on oral adherence. She is a co-author of the recently published ASCO/NCODA Patient-Centered Standards for Medically Integrated Dispensing.  

Mary is a graduate of the University of Kentucky College of Nursing with more than 30 years of experience in oncology nursing. 

Jonas Congelli, RPh, has practiced as an oncology pharmacist since 1990. He currently serves as the chief of Pharmacy, Laboratory and Nutrition Services for Hematology Oncology Associates of Central New York (HOACNY), a large multispecialty community oncology practice with four practice locations, 17 physicians, and 300 employees. Pharmacy services at HOACNY, include: clinical drug information management by oncology pharmacists, infusion chemotherapy delivered from USP 797-certified clean rooms, oral chemotherapy and supportive medications dispensed from The Patient Rx Center, and clinical research support with protocols provided through the Alliance for Clinical Trials in Oncology.

Mr. Congelli graduated from Albany College of Pharmacy in 1989 and has a broad range of oncology experience including hospital inpatient, outpatient, and community oncology practice.

Danielle Duy has 30 years of pharmacy experience. She worked more than two decades as a Pharmacy Technician in retail and long-term care pharmacies. Currently, Ms. Duy holds the position of Pharmacy Access Specialist at SSM Health Cancer Care. As a Pharmacy Access Specialist at SSM, Ms. Duy helps patients navigate financial barriers to acquire medications. Her special interests include improving workflows, patient experience, and customer service. She is active in the Association of Community Cancer Centers Financial Advocacy Network.

Linda Frisk, PharmD, is Pharmacy Manager at Ironwood Research and Cancer Centers in Phoenix, Arizona. Ironwood includes 10 sites of service and one central medically integrated dispensing (MID) location that services all 10 sites. There are 53 medical oncologists and advanced practice providers, 10 radiation oncologists, 8 breast surgeons, and 3 gynecological oncologists as well as urologists within the Ironwood practice. Linda’s role is similar to her prior management role with the addition of an increased emphasis on providing clinical education to the nursing and pharmacy teams. Linda has helped to incorporate therapeutic biosimilars into the practice to comply with payer requirements.

Previously, she served as Pharmacy Manager with Arizona Oncology. Dr. Frisk came to Arizona Oncology in 2004. She was pharmacy manager for their infusion clinics in Phoenix, northern Arizona sites and Tucson area. She was responsible for the drug management for 20 oncology sites as well as implementing in-office dispensing of oral chemotherapy in 12 locations throughout the state. During this time, Linda worked on helping to create a USP <800> mixing site and developed centralized admixture distribution at a substantial reduction of drug waste.

Prior to that, Dr. Frisk spent over 20 years as a hospital pharmacist, working in Med-Surg, ICU, and Oncology Services.

She received her PharmD degree from the University of Nebraska Medical Center in Omaha.

Kirollos Hanna, PharmD, BCPS, BCOP, is the Director of Pharmacy at Minnesota Oncology and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine. Dr. Hanna also serves as an Associate Editor for the Journal of the Advanced Practitioner in Oncology (JADPRO).

Dr. Hanna’s research interests are focused on B-cell malignancies and genitourinary cancers. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, AJHP, Drugs, JOPP, AJMC and JHOP.

Dr. Hanna is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy. He received his Doctor of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital, Nashville, TN and his oncology residency at St. Luke's Mountain States Tumor Institute, Boise, ID.

Dr. Hari is the Armand J. Quick/William F. Stapp Professor of Hematology at the Medical College of Wisconsin, where he is also a chief in the Division of Hematology and Oncology in the Department of Medicine. After attending medical school in India, Dr. Hari completed his training in internal medicine and hematology in the United Kingdom and then in the Medical Oncology and Transplantation Program at the Medical College of Wisconsin. Dr. Hari’s primary clinical interests are in cellular therapies and plasma cell disorders, including multiple myeloma, amyloidosis, and other monoclonal gammopathies.

Krista Nelson, MSW, LCSW, OSW-C, FAOS, serves as manager of oncology social work and program manager for quality and research of Cancer Support Services at Providence Cancer Institute in Portland, Oregon. Over the years, she has specialized in many cancers and is interested in the effect of cancer on the family. Krista defines her role as providing support for people and their families throughout the cancer continuum, and sharing the expertise that she has learned from other patients with cancer. What she loves about working with those affected with cancer is being able to witness the grace, courage and life lessons of individuals dealing with cancer and the opportunity to be a part of their journey.

Nelson served as president of the Association of Community Cancer Centers (ACCC) from 2021-2022.  Nelson is also a Past President of the Board of Directors of the Association of Oncology Social Work (AOSW) and past Invited Director of the American Psychosocial Oncology Society (APOS). She also served as Director on the board of directors of the National Accreditation Program for Breast Centers (NAPBC), and as Director of the American Clinical Social Work Association (ACSWA). In 2019, the Association of Oncology Social Work presented Nelson its Leadership in Oncology Social Work Award.

Nelson received a bachelor's degree from the University of Washington in Seattle, Washington, and a Master of Social Work degree from Portland State University in Portland, Oregon

Kathy W. Oubre, MS, is the Chief Operating Officer for Pontchartrain Cancer Center with locations in Covington and Hammond, Louisiana. In this role, she provides non-clinical leadership for all aspects of the practice, including financial counseling, policy/procedure development, revenue cycle management, advanced care planning, survivorship care and clinical trials.

She is the President of the Coalition of Hematology and Oncology Practices (CHOP) and President-Elect of the Louisiana Medical Group Managers Association. Kathy is also a Board member of the Community Oncology Alliance (COA) and serves on the COA Government Affairs and Biosimilars Committees. She is a member of the Quality Cancer Care Alliance (QCCA) and serves as the Chair of Pharmaceutical and Operational Purchasing. Kathy is also the Advisory Board President for You Night Empowering Events, which is a year-round cancer survivorship program for women. Other memberships include ACCC and National Community Oncology Dispensing Association (NCODA).

Ray D. Page, DO, PhD, FACOI, FASCO, has practiced medical oncology for 23 years. He is President of The Center for Cancer and Blood Disorders and has been at the forefront of community oncology practice transformation participating in a variety of payment reform models and development of pathway systems. As Director of Research for The Center for Cancer and Blood Disorders, Dr. Page has been the Principal Investigator of over 200 clinical trials. He serves on the board, executive committee, and chairs the membership committee of a national oncology “Supergroup”, Quality Cancer Care Alliance. He is the Chief-of-Staff and serves on several committees, including the Graduate Medical Education Committee for the Internal Medicine residency program, and serves on the Board of the Careity Foundation in Fort Worth, Texas.

Dr. Page received his BS in chemistry and biology from Southwestern University in Georgetown, Texas and his MS in physiology at Baylor University Graduate School-Baylor College of Dentistry in Dallas, Texas. He received his Ph.D. in pharmacology and his doctorate in osteopathic medicine. Dr. Page completed his residency in internal medicine at The University of North Texas Health Science Center Osteopathic Medical Center of Texas and completed a combined oncology/hematology fellowship at the University of Texas M. D. Anderson Cancer Center in Houston, Texas.